Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide (Oncogene, (2019), 38, 42, (6867-6879), 10.1038/s41388-019-0927-y)

Ryan T. Nitta, Sara Bolin, Emily Luo, David E. Solow-Cordero, Peyman Samghabadi, Teresa Purzner, Parvir S. Aujla, Ginikachi Nwagbo, Yoon Jae Cho, Gordon Li

Research output: Contribution to journalComment/debate

Abstract

The original version of this Article contained an error in the spelling of the author David Solow-Cordero, which was incorrectly given as David Solow-Codero. This has now been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish (US)
JournalOncogene
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide (Oncogene, (2019), 38, 42, (6867-6879), 10.1038/s41388-019-0927-y)'. Together they form a unique fingerprint.

  • Cite this

    Nitta, R. T., Bolin, S., Luo, E., Solow-Cordero, D. E., Samghabadi, P., Purzner, T., Aujla, P. S., Nwagbo, G., Cho, Y. J., & Li, G. (Accepted/In press). Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide (Oncogene, (2019), 38, 42, (6867-6879), 10.1038/s41388-019-0927-y). Oncogene. https://doi.org/10.1038/s41388-019-1077-y